24.7.15

La importancia del lenguaje en el entorno biosanitario


Para aquellos interesados, y en ocasiones preocupados, por la inadecuada utilización del lenguaje en el ámbito biosantario, la Fundación Dr. Antonio Esteve en colaboración con la Universidad de Salamanca, organizó en mayo de 2014 una mesa redonda con una treintena de expertos en diversas áreas de la divulgación científica. Esta mesa se organizó en cuatro bloques: tres de ellos reflejaron las vertientes principales de la actividad sanitaria profesional: asistencial, investigadora y docente. El cuarto bloque correspondió a la divulgación de la información al conjunto de la sociedad o medios de comunicación.

Todas las ponencias se han recogido en la monografía de la Fundación Dr. Antonio Esteve bajo el título "La importancia del lenguaje en el entorno biosanitario", organizada en  sus cuatro secciones o temáticas:
  1. EL LENGUAJE EN EL ÁMBITO ASISTENCIAL
  2. EL LENGUAJE EN LA INVESTIGACIÓN BIOMÉDICA
  3. EL LENGUAJE EN LA DOCENCIA BIOSANITARIA
  4. EL LENGUAJE COMO PUENTE ENTRE LOS PROFESIONALES BIOSANITARIOS Y LA SOCIEDAD
Esta monografía se encuentra en formato papel en la Biblioteca. También se puede descargar en formato pdf gratuitamente con tan sólo registrarse en su página http://www.esteve.org/monografia-lenguaje/.


Fuente: Diario Médico julio 2015

23.7.15

Guías Fisterra junio y julio 2015



Guías y novedades Fisterra del mes de junio
Guías Clínicas:
Novedades:

2.7.15

Guías NICE, abril, mayo y junio de 2015



 Enlace a todas las guías por especialidad
Abril

Reference Guidance Programme Topic
STA In development  Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416]
Technology appraisal guidance
Systemic lupus erythematosus






Mayo


Junio


Reference Guidance Programme Topic
NG13 Workplace policy and management practices to improve the health and wellbeing of employees  Guideline Workplaces 
NG12 Suspected cancer: recognition and referral  Guideline Cervical cancer 
SFCQS88 NICE support for commissioning for personality disorders: borderline and antisocial  Support for commissioning Personality disorders 
TA339 Omalizumab for previously treated chronic spontaneous urticaria  Technology appraisal guidance Skin conditions: general and other 
TA342 Vedolizumab for treating moderately to severely active ulcerative colitis  Technology appraisal guidance Inflammatory bowel disease 
TA341 Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism  Technology appraisal guidance Embolism and thrombosis 
TA340 Ustekinumab for treating active psoriatic arthritis (rapid review of technology appraisal guidance 313)  Technology appraisal guidance Arthritis 
IPG519 Insertion of an epiretinal prosthesis for retinitis pigmentosa  Interventional procedure guidance Eye conditions: general and other 
IPG521 Suture fixation of acute disruption of the distal tibiofibular syndesmosis  Interventional procedure guidance Musculoskeletal conditions: general and other 
IPG523 Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis  Interventional procedure guidance Embolism and thrombosis 
NG8 Anaemia management in people with chronic kidney disease  Guideline Blood conditions 
DG17 Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index  Diagnostics guidance Prostate cancer 
TA343 Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding 
IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis 
IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids 
QS90 Urinary tract infections in adults  Quality standards Urinary tract infection 
QS91 Prostate cancer  Quality standards Prostate cancer 
QS87 Osteoarthritis  Quality standards Arthritis 
QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders 
QS89 Pressure ulcers  Quality standards Pressure ulcers 
IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions 
IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins 
IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches 
STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis 




TA344 Ofatumumab in combination with chlorambucil or bendamustine for untreated chronic lymphocytic leukaemia  Technology appraisal guidance Blood and bone marrow cancers 
IPG520 Radiofrequency ablation for gastric antral vascular ectasia  Interventional procedure guidance Upper gastrointestinal bleeding 
IPG524 Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism  Interventional procedure guidance Embolism and thrombosis 
IPG522 Hysteroscopic morcellation of uterine leiomyomas (fibroids)  Interventional procedure guidance Endometriosis and fibroids 
QS90 Urinary tract infections in adults  Quality standards Urinary tract infection 
QS91 Prostate cancer  Quality standards Prostate cancer 
QS87 Osteoarthritis  Quality standards Arthritis 
QS88 Personality disorders: borderline and antisocial  Quality standards Personality disorders 
QS89 Pressure ulcers  Quality standards Pressure ulcers 
IPG525 Electrotherapy for the treatment of haemorrhoids  Interventional procedure guidance Haemorrhoids and other anal conditions 
IPG526 Cyanoacrylate glue occlusion for varicose veins  Interventional procedure guidance Varicose veins 
IPG527 Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache  Interventional procedure guidance Headaches 
STA In development  Hepatitis C (chronic) - ledipasvir-sofosbuvir [ID742]  Technology appraisal guidance Hepatitis 
























27.3.15

Guías NICE, enero, febrero y marzo de 2015

Guías de enero y febrero (pinchar en los enlaces correpondientes)
Si lo que desea es localizar guías por tema, pinche en este enlace

MARZO
Reference Guidance Programme Topic
IPG515 Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section
Interventional procedure guidance
Intrapartum care
IPG517 Insertion of endobronchial nitinol coils to improve lung function in emphysema
Interventional procedure guidance
Chronic obstructive pulmonary disease
QS84 Physical activity: encouraging activity in all people in contact with the NHS
Quality standards
Physical activity
TA337 Rifaximin for preventing episodes of overt hepatic encephalopathy
Technology appraisal guidance
Liver conditions: general and other
QS85 Managing medicines in care homes
Quality standards
Medicines management: general and other
TA336 Empagliflozin in combination therapy for treating type 2 diabetes
Technology appraisal guidance
Diabetes
QS82 Smoking: reducing tobacco use
Quality standards
Smoking and tobacco
QS86 Falls in older people: assessment after a fall and preventing further falls
Quality standards
Injuries, accidents and wounds: general and other
TA338 Pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
Technology appraisal guidance
Blood and bone marrow cancers
QS83 Alcohol: preventing harmful alcohol use in the community
Quality standards
Communities
IPG514 Transanal total mesorectal excision of the rectum
Interventional procedure guidance
Colorectal cancer
IPG516 Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation
Interventional procedure guidance
Cardiovascular conditions: general and other
IPG518 Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
Interventional procedure guidance
Diabetes
MTG24 The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
Medical technology guidance
Surgical care
TA335 Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
Technology appraisal guidance
Acute coronary syndromes
IPG512 Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis
Interventional procedure guidance
Knee conditions
NG7 Maintaining a healthy weight and preventing excess weight gain among adults and children
Guideline
Diet, nutrition and obesity
NG6 Excess winter deaths and morbidity and the health risks associated with cold homes
Guideline
Vulnerable groups
NG5 Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
Guideline
Medicines management: general and other
CG28 Depression in children and young people: Identification and management in primary, community and secondary care
Clinical guidelines
Children and young people